Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

CI-958 for treatment of prostate cancer

Sep. 20, 1996

XR-5000 advances through clinical trials

Sep. 20, 1996

Further approval recommended for Novantrone

Sep. 20, 1996

SAMDC inhibitors from Ciba-Geigy

Sep. 20, 1996

Nitrogen mustard prodrugs from CRC Technology

Sep. 20, 1996

Daiichi's anticancer drugs in development

Sep. 13, 1996

Chugai's anticancer R&D pipeline

Sep. 13, 1996

Expanded approval sought for Photofrin

Sep. 13, 1996

Cytoprotective agent receives broad approval in Australia

Sep. 13, 1996

DNA repair gene isolated

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...